Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7935796 Monoclonal antibodies against ANGPTL3

Patent 7935796 was granted and assigned to Lexicon Pharmaceuticals, Inc. on May, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11926660 Anti-ApoE antibodies
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11866709 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840692 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834662 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
0
Edits on 27 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 27 Nov, 2023
Edits made to:
Article (+275 characters)
Article

Patent abstract

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

Edits on 13 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 13 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07935796 Monoclonal antibodies against ANGPTL3 US Patent 7935796 Monoclonal antibodies against ANGPTL3

Infobox
Patent Number
0793579600
Patent Number
793579600
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0793579600
Edits on 30 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
Lexicon Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
079357960
Date of Patent
May 3, 2011
0
Patent Application Number
120010120
Date Filed
December 6, 2007
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079357960
Patent Primary Examiner
‌
Sharon Wen
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
Lexicon Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
079357960
Date of Patent
May 3, 2011
0
Patent Application Number
120010120
Date Filed
December 6, 2007
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079357960
Patent Primary Examiner
‌
Sharon Wen
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07935796
Edits on 7 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07935796 Monoclonal antibodies against ANGPTL3

Infobox
Is a
Patent
Patent
Current assignee
‌
Lexicon Pharmaceuticals, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07935796
Date of patent
May 3, 2011
Patent application number
12001012
Date Filed
December 6, 2007
Patent primary examiner
‌
Sharon Wen

Find more entities like US Patent 7935796 Monoclonal antibodies against ANGPTL3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.